Congo vs Namibia: Population requiring preventive chemotherapy for schistosomiasis
Congo
151,745
in 2024
Namibia
196,714
in 2024
Congo rank
45th
Namibia rank
43rd
Population requiring preventive chemotherapy for schistosomiasis over time
- Congo
- Namibia
How they compare
Namibia currently reports 196,714 against 151,745 in Congo, a difference of 44,969.
That makes Namibia's figure about 1.3 times Congo's.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Namibia ahead.
Congo ranks 45th and Namibia ranks 43rd of 52 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Namibia in 1.
Head to head by decade
| Decade | Congo | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 267,052 | 324,831 | 57,779 | Namibia |
| 2020s | 348,377 | 192,808 | 155,568 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Congo or Namibia?
- Namibia, at 196,714 against 151,745 in Congo as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Congo and Namibia?
- 44,969, with Namibia ahead.
- How many years of comparable data are there for Congo and Namibia?
- 15 years are reported by both, from 2010 to 2024.
- How do Congo and Namibia rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Congo ranks 45th and Namibia ranks 43rd of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.